Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.810
+0.350 (10.12%)
At close: Aug 13, 2025, 4:00 PM
3.650
-0.160 (-4.20%)
Pre-market: Aug 14, 2025, 9:12 AM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $499.50 million as of August 14, 2025. Its market cap has decreased by -22.44% in one year.
Market Cap
499.50M
Enterprise Value
517.48M
1-Year Change
-22.44%
Ranking
Category
Stock Price
$3.81
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $499.50M, a decrease of -69.31%. That is a compound annual growth rate of -34.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 499.50M | 34.06% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |